Markets · Europe · Swiss

ROP.SW Roche Holding AG

CHF 352.70 -2.03%

Europe · Health care

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-2.03%

YTD

+21.10%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

0.03

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

CHF 357.90

CHF 352.70

VWAP (n/a)

—

Day high

CHF 358.00

Day low

CHF 352.50

Volume

859K

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

Roche Holding (SWX:ROP) Ebola Testing Support Keeps Fair Value In Focus

Yahoo Finance · Oct 9

FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer

Yahoo Finance · Oct 8

Point-of-Care Testing, Falling Prices and PCR Threaten the Immunoassay Lab Model: What Diagnostics Leaders Must Do Next

Yahoo Finance · Oct 8

PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher

Yahoo Finance · Oct 8

Roche (SWX:ROP) Stock Looks Undervalued Despite Recent Pipeline Progress

Yahoo Finance · Oct 8

Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players

Yahoo Finance · Oct 7

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell ROP.SW. Try it in the Lab to size a position and see the risk.